U.S. Dermatology Partners Opens New Office in Arlington, Texas
New Arlington clinic expands patient access to dermatology care across North TexasARLINGTON, Texas, March 9, 2026 /PRNewswire/ -- U.S. Dermatology...
Read moreDetails
Uncategorized
Kelun-Biotech and Harbour BioMed Announce NMPA Approval of IND Application for SKB575/HBM7575 for the Treatment of Atopic Dermatitis
CHENGDU, China, March 9, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) and Harbour BioMed...
Read moreDetailsLUCA STRENGTHENS TECHNICAL LEADERSHIP WITH APPOINTMENT OF COO AND BUILDS TEAM TO EXECUTE ON MINE OPTIMIZATIONS
VANCOUVER, BC, March 9, 2026 /PRNewswire/ - Luca Mining Corp. ("Luca" or the "Company") (TSX-V: LUCA) (OTCQX: LUCMF) (Frankfurt: Z68) is...
Read moreDetails
Vision Marine Technologies Introduces 6-Year Limited Powertrain Warranty for E-Motion™ 180E Product & Technology Update
First High-Voltage Electric Outboard Above 150 HP to Offer This Level of Standard Coverage in North AmericaMONTREAL, March 9, 2026...
Read moreDetailsCGI achieves Databricks Gold tier status, recognizing its AI, data and analytics delivery capabilities
Stock Market SymbolsGIB.A (TSX)GIB (NYSE)cgi.com/newsroomCGI also earned Brickbuilder Specializations in Security & Governance and Manufacturing, Transportation & EnergyMONTRÉAL, March 9,...
Read moreDetailsChicago Faucets at PDC Summit, Showcasing +Healthcare Plumbing Solutions
Portfolio highlights reliability, safety, and specification confidence for healthcare construction and design professionalsDES PLAINES, Ill., March 9, 2026 /PRNewswire/ -- Chicago...
Read moreDetailsPhothera Launches Guided Mode for Home Phototherapy Treatments for Chronic Skin Conditions
Clinically validated on-device app delivers smartphone-level simplicity with built-in safety controls CLEVELAND, March 9, 2026 /PRNewswire/ -- Phothera, the leading manufacturer of FDA-cleared light therapy...
Read moreDetailsIDEAYA Biosciences Announces First-Patient-In for Phase 1 Trial of IDE892, a Potential Best-In-Class PRMT5 Inhibitor for MTAP-Deleted Solid Tumors, and Provides MTAP and CDKN2A Pipeline Update
Potential best-in-class profile, including ~1,400-fold selective binding to MTA-PRMT5 versus SAM-PRMT5 complexes, and single-digit nanomolar potency in MTAP-deleted cell linesIDE892...
Read moreDetailsAstro Pak Appoints Kyle Campbell as Senior Vice President of Field Services
COSTA MESA, Calif., March 9, 2026 /PRNewswire/ -- Astro Pak LLC ("Astro Pak"), a portfolio company of The Stephens Group,...
Read moreDetailsCLEAR AND OCHSNER HEALTH PARTNER TO IMPROVE HEALTHCARE EXPERIENCES ACROSS LOCATIONS IN LOUISIANA, MISSISSIPPI, AND ALABAMA
Expansion of CLEAR1 to Three New States Demonstrates Fast-Growing Adoption of Seamless Patient and Employee ExperiencesNEW YORK, March 9, 2026...
Read moreDetails